Shawn Tomasello

Shawn Tomasello has an estimated net worth of $20.8 Million. This is based on reported shares across multiple companies, which include Gamida Cell Ltd., Allovir, Inc., 4D Molecular Therapeutics, Inc., Diplomat Pharmacy, Inc., UroGen Pharma Ltd., TCR2 THERAPEUTICS INC., Principia Biopharma Inc., Kite Pharma, Inc., ABEONA THERAPEUTICS INC., Cabaletta Bio, Inc., and PHARMACYCLICS INC.

2023 was Shawn Tomasello's most active year for acquiring shares with 9 total transactions. Shawn Tomasello's most active month to acquire stocks was the month of May. 2017 was Shawn Tomasello's most active year for disposing of shares, totalling 7 transactions. Shawn Tomasello's most active month to dispose stocks was the month of April. 2026 saw Shawn Tomasello paying a total of $50,322.24 for 22,725 shares, this is the most they've acquired in one year. In 2015 Shawn Tomasello cashed out on 157,504 shares for a total of $15,022,920.00, their largest year based on trade value.